1. Home
  2. NEWS
  3. Porosome Therapeutics Announces its Patent Estate Review Results: “The strategic analysis confirmed that Porosome Therapeutics occupies a distinct and defensibleintellectual property position within the emerging field of secretion restoration technologies. Porosome Therapeutics has successfully carved out a highly defensible white space” (March 11, 2026)

Porosome Therapeutics Announces its Patent Estate Review Results: “The strategic analysis confirmed that Porosome Therapeutics occupies a distinct and defensibleintellectual property position within the emerging field of secretion restoration technologies. Porosome Therapeutics has successfully carved out a highly defensible white space” (March 11, 2026)

Porosome Therapeutics Announces its Patent Estate Review Results: “The strategic analysis confirmed that Porosome Therapeutics occupies a distinct and defensibleintellectual property position within the emerging field of secretion restoration technologies. Porosome Therapeutics has successfully carved out a highly defensible white space” (March 11, 2026)
Forbes Magazine Features Professor Bhanu Jena
Prof. Bhanu P. Jena to present the first Plenary Keynote Lecture entitled "Development of a New Class of AI-Engineered Porosome Medicines" at the Bio Week Boston on September 24th 2026 being held at the Hynes Convention Center, Boston. Over 5000 attendees from 48 countries will be participating.
Porosome Therapeutics Chairman Prof. Bhanu P. Jena is Co-Chair in the World Congress in Nanomedicine being held in New Delhi (September 27 - 30th, 2026) and Chaired by Prof. Roger D. Kornberg, 2006 Nobel Laureate in Chemistry.